Clinical Trials Logo
  1. Home
  2. Lung Cancer
  3. NCT03215537
  4. Details
NCT03215537 Clinical Trial

Development of Patient Tailored Guideline of Physical Activity for Lung Cancer

Lung Cancer Clinical Trial

Official title:
Development of Patient Tailored Guideline of Physical Activity for Lung Cancer Survivor After Surgery; to Improve the Symptoms, Complications and Quality of Life

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT03215537
Other study ID # 2015-11-025-002
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 2, 2016
Est. completion date December 2, 2023

Study information
Verified date February 2021
Source Samsung Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to propose a perioperative comprehensive intervention based on health behavior model to improve cardiopulmonary function and quality of life among lung cancer patients following

Description:

This study aims to propose a perioperative comprehensive intervention based on health behavior model to improve cardiopulmonary function and quality of life among lung cancer patients following: 1. understanding multi-dimensional factors affecting cardiopulmonary function and quality of life 2. development of multidisciplinary comprehensive intervention 3. evaluation the effects of comprehensive intervention using cluster design

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 176
Est. completion date December 2, 2023
Est. primary completion date November 16, 2020
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - lung cancer patients before surgery Exclusion Criteria: - Eastern Cooperative Oncology Group Performance Status <1 - Neoadjuvant therapy - Multiple cancer - Recurrent lung cancer.

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• comprehensive intervention
preoperative and postoperative exercise program

Locations
Country Name City State
Korea, Republic of Samsung Medical Center Seoul

Sponsors (1)
Lead Sponsor Collaborator
Samsung Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary Changes of cardiopulmonary function six minute walk test Baseline, 1 month after surgery, 6 months after surgery, 1year after surgery
Secondary complication Pneumonia 1 month after surgery, 6 months after surgery, 1year after surgery
Secondary Changes of pulmonary function forced expiratory volume at one second, forced vital capacity Baseline, 1 month after surgery, 6 months after surgery, 1year after surgery
Secondary Changes of physical activity wearable device Baseline, 1 month after surgery, 6 months after surgery, 1year after surgery
Secondary Changes of physical fitness muscle strengths Baseline, 1 month after surgery, 6 months after surgery, 1year after surgery
Secondary Changes of quality of life quality of life questionnaire Baseline, 1 month after surgery, 6 months after surgery, 1year after surgery
Secondary Changes of Fatigue Fatigue questionnaire Baseline, 1 month after surgery, 6 months after surgery, 1year after surgery
See also
  Status Clinical Trial Phase
Completed NCT03918538 - A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors N/A
Recruiting NCT05078918 - Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors N/A
Active, not recruiting NCT04548830 - Safety of Lung Cryobiopsy in People With Cancer Phase 2
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Not yet recruiting NCT06376253 - A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Phase 1
Recruiting NCT05898594 - Lung Cancer Screening in High-risk Black Women N/A
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Active, not recruiting NCT03575793 - A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Phase 1/Phase 2
Terminated NCT01624090 - Mithramycin for Lung, Esophagus, and Other Chest Cancers Phase 2
Terminated NCT03275688 - NanoSpectrometer Biomarker Discovery and Confirmation Study
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Recruiting NCT06052449 - Assessing Social Determinants of Health to Increase Cancer Screening N/A
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Recruiting NCT05787522 - Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk